Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy

International Journal of Urology

Volumn 15, Issue 11, 2008, Pages 997-1001

  Cam, Kamil ^a   Kayikci, Ali ^a   Akman, Yavuz ^a   Erol, Ali ^a  

^a DUZCE UNIVERSITY   (Turkey)

Author keywords

Antibiotics; Biopsy; Prophylaxis; Prostate; Urinary tract infection

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DYSURIA; FEVER; HEMATURIA; HEMOSPERMIA; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; SINGLE DRUG DOSE; TRANSRECTAL ULTRASONOGRAPHY; URINALYSIS; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION;

AGED; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOPSY, NEEDLE; CEFTRIAXONE; CIPROFLOXACIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RECTUM; RISK ASSESSMENT; URINARY TRACT INFECTIONS;

EID: 54849420720     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02147.x     Document Type: Article

References (23)

1. Aus G, Abbou CC, Bolla M et al. EAU guidelines on prostate cancer. Eur. Urol. 2005 48 : 546 51.
2. Ochiai A, Babaian RJ. Update on prostate biopsy technique. Curr. Opin. Urol. 2004 14 : 157 62.
3. Djavan B. Prostate biopsies and the Vienna nomograms. Eur. Urol. 2006 5 (Suppl 500 10.
4. Aus G, Ahlgren G, Bergdahl S, Hugosson J. Infection after transrectal core biopsies of the prostate - risk factors and antibiotic prophylaxis. Br. J. Urol. 1996 77 : 851 5.
5. Shandera KC, Thibault GP, Deshon GE Jr. Variability in patient preparation for prostate biopsy among American urologists. Urology 1998 52 : 644 6.
6. Matlaga BR, Eskew LA, McCullough DL. Prostate biopsy: indications and technique. J. Urol. 2003 169 : 12 19.
7. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005 55 : 74 108.
8. Bratzler DW, Houck PM, Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am. J. Sur. 2005 189 : 395 404.
9. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch. Intern. Med. 2003 163 : 972 8.
10. Bentley FD, Kitchens DM, Bell TE. Antimicrobial prophylaxis and patient preparation for transrectal prostate biopsy: Review of the literature and analysis of cost-effectiveness. Infect. Urol. 2003 16 : 3 12.
11. Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Harpster LE. Antibiotic prophylaxis in ultrasound guided prostate biopsy. J. Urol. 1997 157 : 2199 200.
12. Kapoor DA, Klimberg IW, Malek GH et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998 52 : 552 8.
13. Alerany C, Campany D, Monterde J, Semeraro C. Impact of local guidelines and an integrated dispensing system on antibiotic prophylaxis quality in a surgical centre. J. Hosp. Infect. 2005 60 : 111 17.
14. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int. 2000 85 : 682 5.
15. Lindstedt S, Lindstrom U, Ljunggren E, Wullt B, Grabe M. Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors. Eur. Urol. 2006 50 : 832 7.
16. Shigemura K, Tanaka K, Yasuda M et al. Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. World J. Urol. 2005 23 : 356 60.
17. Sabbagh R, McCormack M, Peloquin F et al. A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can. J. Urol. 2004 11 : 2216 19.
18. Shandera KC, Thibault GP, Deshon GE Jr. Efficacy of one dose fluoroquinolone before prostate biopsy. Urology 1998 52 : 641 3.
19. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J. Urol. 1998 159 : 471 6.
20. Burden HP, Ranasinghe W, Persad R. Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practising evidence-based medicine? BJU Int. 2008 101 : 1202 4.
21. Yu X, Susa M, Weile J, Knabbe C, Schmid RD, Bachmann TT. Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray. Int. J. Med. Microbiol. 2007 297 : 417 29.
22. Miura T, Tanaka K, Shigemura K, Nakano Y, Takenaka A, Fujisawa M. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature. Int. J. Urol. 2008 15 : 457 9.
23. Yamamoto S, Ishitoya S, Segawa T, Kamoto T, Okumura K, Ogawa O. Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin. Int. J. Urol. 2008 15 : 604 606.